Literature DB >> 20600482

Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan.

Megumi Hara1, Keitaro Tanaka, Tetsuo Kase, Akiko Maeda, Yoshio Hirota.   

Abstract

Influenza vaccination efficacy was evaluated in 114 institutionalized elderly people in 2002/03. Strain A/H3N2 was isolated; 44 and 8 subjects had sudden-onset fever (> or = 37.8 degrees C) and kit-diagnosed influenza, respectively. Odds ratios adjusted for age, sex, comorbidity, and vaccine strain (OR(adj)) were determined using multiple logistic regression. Seroprotected patients (haemagglutination-inhibition antibody titre > or = 1:40) had lower incidence of fever (OR(adj), 0.35; 95% confidence interval [CI], 0.09-1.28) and kit-diagnosed influenza (OR(adj), 0.35; 95% CI, 0.03-4.64) than patients without seroprotection (antibody efficacy, approximately 65%). Seroprotective levels of vaccination-induced antibodies probably prevent influenza among the institutionalized elderly, although statistical significance could not be confirmed owing to the sample size. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600482     DOI: 10.1016/j.vaccine.2010.06.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088).

Authors:  Adriana Weinberg; Petronella Muresan; Terence Fenton; Kelly Richardson; Teresa Dominguez; Anthony Bloom; Elizabeth Petzold; Patricia Anthony; Coleen K Cunningham; Stephen A Spector; Sharon Nachman; George K Siberry; Edward Handelsman; Patricia M Flynn
Journal:  Hum Vaccin Immunother       Date:  2013-01-31       Impact factor: 3.452

2.  Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza Season.

Authors:  Megumi Hara; Tomoyuki Hanaoka; Kazuhiro Maeda; Tetsuo Kase; Satoko Ohfuji; Wakaba Fukushima; Yoshio Hirota
Journal:  J Epidemiol       Date:  2016-01-16       Impact factor: 3.211

3.  A randomized controlled trial to evaluate the effect of influenza vaccination and probiotic supplementation on immune response and incidence of influenza-like illness in an elderly population in Indonesia.

Authors:  Sukamto Koesnoe; Nuning Masjkuri; Asri Adisasmita; Samsuridjal Djauzi; Cissy Kartasasmita; Julitasari Sundoro; Mardiati Nadjib; Mondastri Korib; Alisa Nurul Muthia; Virly Nanda Muzellina; Ummu Habibah; Saskia Aziza Nursyirwan; Kristoforus Hendra Djaya; Novilia Sjafri Bachtiar; Rini Mulia Sari
Journal:  PLoS One       Date:  2021-12-16       Impact factor: 3.240

Review 4.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.